BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
(OTTAWA, ON – June 27, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG (Bayer) to supply high-purity Actinium-225 (Ac-225).
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes.
BWXT to Build First Advanced Microreactor in United States
(LYNCHBURG, Va. – June 9, 2022) – BWX Technologies, Inc. (NYSE: BWXT) will build the first advanced nuclear microreactor in the United States under a contract awarded by the U.S. Department of Defense (DoD) Strategic Capabilities Office (SCO). The Project Pele full-scale transportable microreactor prototype will be completed and delivered in 2024 for testing at the Idaho National Laboratory.
BWXT Names Ryan Colvert as Senior Director for Government Relations
(LYNCHBURG, Va. – May 16, 2022) – BWX Technologies, Inc. (NYSE: BWXT) has hired Ryan B. Colvert as a senior director for government relations.
BWXT Appoints Jan A. Bertsch as New Chair of Board of Directors
(LYNCHBURG, Va. – May 3, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that Jan A. Bertsch has been elected as its new chair of the board of directors, effective May 3, 2022, succeeding retiring board chairman John A. Fees.
BWXT Named to the World’s Top 100 Most Transparent Companies
(LYNCHBURG, Va. – April 14, 2022) – BWX Technologies, Inc. (NYSE: BWXT) was recently named by Transparency Global as one of the world’s top 100 most transparent companies for the second quarter.
BWXT Advancing Microreactor Design Project
(LYNCHBURG, Va. – April 11, 2022) – BWX Technologies, Inc. (NYSE: BWXT) is proceeding apace to deliver microreactors to commercial power and industrial customers in cooperation with Idaho National Laboratory and Oak Ridge National Laboratory.
BWX Technologies to Announce First Quarter 2022 Results on Monday, May 9 and Issues Interim Update on Key Initiatives
(LYNCHBURG, Va. – March 30, 2022) – BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing first quarter 2022 results on Monday, May 9, 2022, after market close and will host a conference call at 5:00 p.m. EDT.